Afren Plc Is Still Horribly Overvalued

Afren Plc (LON: AFR) shares are still too expensive at 3.8p!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At 3.8p, Afren (LSE: AFR) shares are down 97% over the past 12 months. That reflects the fact that the company is technically insolvent, has defaulted on some loan interest payments, and was on the verge of collapse. So now that there’s a rescue package on the table, all’s going to be well and the shares are worth picking up ready for the recovery that’s sure to come?

Oh no. I previously opined that you’d have been mad to buy Afren shares at 10p, and I still think you’d be mad to buy them today at 3.8p. Let me tell you why…

Massive dilution

The proposed rescue package announced on 13 March will lead to substantial dilution of the existing shareholders’ interests, and the share price duly fell on the news. But I don’t think the market has fully grasped the scale of the dilution. A large portion of Afren’s current debts will be converted into shares, and there will be a tranche of new bonds issued in order to raise more debt capital.

There will be more shares issued and offered to some bondholders too, and the overall result should be to save Afren from going bust. But the bailout will only reduce debt by a modest amount, and after the dilution, existing shareholders will be left with only 11% of the resulting equity in the company! And even then, it’s conditional on their taking up a new $75m equity offering!

You see, the new rescue package has to be massively attractive to new lenders in order for them to take part, and in effect they’ll be eventually getting their money back with high bond rates, and they’ll be getting to own a huge chunk of the company into the bargain.

New equity price?

And what about the pricing of new shares? Well, there’s some scary stuff there too.

Shares have what’s called a nominal value, which is usually considerably lower than their market price. In Afren’s case, there’s a nominal value of 1p per share. And get this — Afren plans to lower the nominal value to prevent the embarrassing possibility of issuing shares for less than that!

That’s a huge hint that we’ll see new equity priced at a substantial discount to the current share price and maybe even below one penny per share!

So why has the price not crashed further than it has? It’s possible that investors did not fully absorb the true reality of the situation when they read the news, and since then the price has slipped further as presumably people have had time to digest things — on the day we only saw a fall to 5p.

It’s also possible that shareholders might be aiming to withhold their approval of the plan in the hope of getting something more attractive. But Afren has already hinted that there’s no better alternative to come — and creditors could pull the plug today if they want.

The sad truth

Current shareholders need to accept the sad truth — you’ve lost your company to its creditors, and anything you’ll be left with will be practically worthless.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has recommended Afren. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Landlady greets regular at real ale pub
Investing Articles

101 Diageo shares bought 12 months ago are now worth…

Diageo shares have strong momentum so far this year. The question is, can the FTSE 100 drinks stock keep on…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Why does the FTSE 100 keep outperforming the S&P 500?

The FTSE 100 has outperformed the S&P 500 in 2025 and in the early days of 2026. What's happening here?…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

£1,000 buys 11,500 shares in this red hot healthcare penny stock that’s smashing GSK

This healthcare stock has delivered around twice the return of GSK shares in 2026. Believe it or not though, it…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

This little known UK growth share is up 387% in five years. Time to buy?

Christopher Ruane looks at some pros and cons of a UK growth share that has been increasing its revenues significantly.…

Read more »

National Grid engineers at a substation
Investing Articles

Here’s how long it might take 100 National Grid shares to pay for themselves with dividends

With a dividend policy that aims to keep pace with inflation, National Grid shares appeal to some income investors. What…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Under £5 now, are Barclays shares a screaming bargain following excellent 2025 results?

Barclays shares still look way too low to me, given rising earnings and big capital returns ahead — raising the…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Just a £5,000 holding in BP shares could generate £1,807 in annual income for investors over time!

BP shares are throwing off far more dividend income than most investors realise -- and the latest numbers hint the…

Read more »

Middle aged businesswoman using laptop while working from home
Investing Articles

I’m itching to buy Barclays for my Stocks and Shares ISA. But am I too late?

Harvey Jones is looking to generate some income and growth from this year Stocks and Shares ISA allowance. But is…

Read more »